MENU
+Compare
ARMP
Stock ticker: ASE
AS OF
Sep 5 closing price
Price
$2.85
Change
-$0.12 (-4.04%)
Capitalization
103.26M

ARMP Armata Pharmaceuticals Forecast, Technical & Fundamental Analysis

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology... Show more

Industry: #Biotechnology
ARMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ARMP with price predictions
Sep 04, 2025

ARMP's Stochastic Oscillator penetrating overbought zone

The Stochastic Oscillator for ARMP moved into overbought territory on September 04, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ARMP moved out of overbought territory on September 04, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARMP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ARMP broke above its upper Bollinger Band on September 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 03, 2025. You may want to consider a long position or call options on ARMP as a result. In of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ARMP just turned positive on September 03, 2025. Looking at past instances where ARMP's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where ARMP advanced for three days, in of 245 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 127 cases where ARMP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARMP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (19.994). P/E Ratio (0.000) is within average values for comparable stocks, (51.700). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.073). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (325.279).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARMP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ARMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ARMP is expected to report earnings to rise 11.11% to -50 cents per share on November 12

Armata Pharmaceuticals ARMP Stock Earnings Reports
Q3'25
Est.
$-0.50
Q2'25
Missed
by $0.06
Q1'25
Missed
by $0.04
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.13
The last earnings report on August 12 showed earnings per share of -44 cents, missing the estimate of -38 cents. With 8.74K shares outstanding, the current market capitalization sits at 103.26M.
A.I. Advisor
published General Information

General Information

a developer of novel bacteriophage-based therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
5005 McConnell Avenue
Phone
+1 310 665-2928
Employees
66
Web
https://www.armatapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STLJF57.541.46
+2.60%
Stella Jones Inc.
NDEKF22.77N/A
N/A
Nitto Denko Corp.
PRYNF0.05N/A
N/A
Backstageplay Inc.
OISXF7.47N/A
N/A
OISIX RA Daichi Inc.
FIGP17.25N/A
N/A
Forge Group Inc.

ARMP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARMP has been loosely correlated with PTIX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ARMP jumps, then PTIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARMP
1D Price
Change %
ARMP100%
-4.04%
PTIX - ARMP
43%
Loosely correlated
+1.61%
NRXS - ARMP
38%
Loosely correlated
-1.30%
TNGX - ARMP
31%
Poorly correlated
+1.61%
BOLT - ARMP
28%
Poorly correlated
+7.23%
FGHQF - ARMP
25%
Poorly correlated
N/A
More